Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients.

The consumer goods giant reiterated its full-year guidance after underlying sales grew more than expected in the third quarter as shoppers welcomed easing price hikes and began buying more of the company’s branded products.

Unilever (NYSE:UL) gained 2.8% in premarket trade, after the consumer goods company's Q3 underlying sales growth came in better than expected. UL reported underlying sales growth of 4.5% in the third quarter,

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients. However,